Importer of Controlled Substances Application: Research Triangle Institute, 2571-2575 [2019-01523]
Download as PDF
2571
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Drug
code
Controlled substance
Beta-hydroxythiofentanyl .........................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................................
Amphetamine ...........................................................................................................................................................................
Methamphetamine ...................................................................................................................................................................
Codeine ...................................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................................
Oxycodone ...............................................................................................................................................................................
Hydromorphone .......................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................................
Isomethadone ..........................................................................................................................................................................
Methadone ...............................................................................................................................................................................
Methadone intermediate ..........................................................................................................................................................
Morphine ..................................................................................................................................................................................
Thebaine ..................................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................................
Oxymorphone ..........................................................................................................................................................................
Thiafentanil ..............................................................................................................................................................................
Alfentanil ..................................................................................................................................................................................
Sufentanil .................................................................................................................................................................................
Carfentanil ...............................................................................................................................................................................
Fentanyl ...................................................................................................................................................................................
The company plans to manufacture
the listed controlled substances to make
reference standards which will be
distributed to their customers.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
[FR Doc. 2019–01510 Filed 2–6–19; 8:45 am]
ACTION:
Notice of registration.
BILLING CODE 4410–09–P
The registrant listed below
has applied for and been granted a
SUMMARY:
FR Docket
Sigma Aldrich Co., LLC .................................................................................................................................
83 FR 60903
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
Dated: January 3, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01521 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Research Triangle
Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 11, 2019. Such persons
may also file a written request for a
DATES:
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
registration by the Drug Enforcement
Administration (DEA) as an importer of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for this notice.
Company
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrant to import the applicable
basic classes of schedule I and II
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security system, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I and II controlled substances
to the above listed company.
9836
9843
1100
1105
9050
9120
9143
9150
9193
9226
9250
9254
9300
9333
9648
9652
9729
9737
9740
9743
9801
Schedule
Published
November 27, 2018.
hearing on the application on or before
March 11, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
E:\FR\FM\07FEN1.SGM
07FEN1
2572
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on May 2,
2016, Research Triangle Institute, 3040
East Cornwallis Road, Hermann Bldg.,
Room 106, Research Triangle Park,
North Carolina 27709 has applied to be
registered as an importer of the
following basic classes of controlled
substances.
Drug
code
Controlled substance
3-Fluoro-N-methylcathinone (3-FMC) ......................................................................................................................................
Cathinone ................................................................................................................................................................................
Methcathinone .........................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ......................................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ........................................................................................................................................
Naphyrone ...............................................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................................
Fenethylline .............................................................................................................................................................................
Aminorex ..................................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................................
Methaqualone ..........................................................................................................................................................................
Mecloqualone ..........................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..........................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .........................................................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .........................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..............................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ...............................................................................................................................
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole3-carboxamide) ...................................................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ............................................................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)1H-indazole-3-carboxamide ...........................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .................
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..........................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ......................................................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...........................................................................................................
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ..............................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..............................................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ..........................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ................................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ...................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ..........................................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ......................................................................................
Alpha-ethyltryptamine ..............................................................................................................................................................
Ibogaine ...................................................................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .........................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...................................................
Lysergic acid diethylamide ......................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ........................................................................................................
Marihuana ................................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................................
Parahexyl .................................................................................................................................................................................
Mescaline .................................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ....................................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .....................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................................
Peyote ......................................................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .........................................................................................................................................
VerDate Sep<11>2014
18:55 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
E:\FR\FM\07FEN1.SGM
07FEN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7011
7012
7019
7023
7024
7031
7032
7035
7048
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7360
7370
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7415
7431
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2573
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Drug
code
Controlled substance
Alpha-methyltryptamine ...........................................................................................................................................................
Bufotenine ................................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................................
Psilocybin .................................................................................................................................................................................
Psilocyn ...................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ......................................................................................................................................
N-Ethyl-3-piperidyl benzilate ....................................................................................................................................................
N-Methyl-3-piperidyl benzilate .................................................................................................................................................
N-Benzylpiperazine ..................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .............................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) ..........................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) ............................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) .........................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ................................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ...........................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) .............................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ......................................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) ............................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) .............................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) .............................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) ..................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................................
Butylone ...................................................................................................................................................................................
Pentylone .................................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ............................................................................................................
Acetyldihydrocodeine ...............................................................................................................................................................
Benzylmorphine .......................................................................................................................................................................
Codeine-N-oxide ......................................................................................................................................................................
Cyprenorphine .........................................................................................................................................................................
Desomorphine .........................................................................................................................................................................
Etorphine (except HCl) ............................................................................................................................................................
Codeine methylbromide ...........................................................................................................................................................
Dihydromorphine .....................................................................................................................................................................
Difenoxin ..................................................................................................................................................................................
Heroin ......................................................................................................................................................................................
Hydromorphinol .......................................................................................................................................................................
Methyldesorphine ....................................................................................................................................................................
Methyldihydromorphine ...........................................................................................................................................................
Morphine methylbromide .........................................................................................................................................................
Morphine methylsulfonate .......................................................................................................................................................
Morphine-N-oxide ....................................................................................................................................................................
Myrophine ................................................................................................................................................................................
Nicocodeine .............................................................................................................................................................................
Nicomorphine ...........................................................................................................................................................................
Normorphine ............................................................................................................................................................................
Pholcodine ...............................................................................................................................................................................
Thebacon .................................................................................................................................................................................
Acetorphine ..............................................................................................................................................................................
Drotebanol ...............................................................................................................................................................................
Acetylmethadol ........................................................................................................................................................................
Allylprodine ..............................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..............................................................................................................
Alphameprodine .......................................................................................................................................................................
Alphamethadol .........................................................................................................................................................................
Benzethidine ............................................................................................................................................................................
Betacetylmethadol ...................................................................................................................................................................
Betameprodine ........................................................................................................................................................................
Betamethadol ...........................................................................................................................................................................
Betaprodine .............................................................................................................................................................................
Clonitazene ..............................................................................................................................................................................
Dextromoramide ......................................................................................................................................................................
Diampromide ...........................................................................................................................................................................
Diethylthiambutene ..................................................................................................................................................................
Dimenoxadol ............................................................................................................................................................................
Dimepheptanol .........................................................................................................................................................................
VerDate Sep<11>2014
18:55 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
E:\FR\FM\07FEN1.SGM
07FEN1
7432
7433
7434
7435
7437
7438
7439
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9051
9052
9053
9054
9055
9056
9070
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9615
9616
9617
9618
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2574
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Drug
code
Controlled substance
Dimethylthiambutene ...............................................................................................................................................................
Dioxaphetyl butyrate ................................................................................................................................................................
Dipipanone ...............................................................................................................................................................................
Ethylmethylthiambutene ..........................................................................................................................................................
Etonitazene ..............................................................................................................................................................................
Etoxeridine ...............................................................................................................................................................................
Furethidine ...............................................................................................................................................................................
Hydroxypethidine .....................................................................................................................................................................
Ketobemidone ..........................................................................................................................................................................
Levomoramide .........................................................................................................................................................................
Levophenacylmorphan ............................................................................................................................................................
Morpheridine ............................................................................................................................................................................
Noracymethadol .......................................................................................................................................................................
Norlevorphanol ........................................................................................................................................................................
Normethadone .........................................................................................................................................................................
Norpipanone ............................................................................................................................................................................
Phenadoxone ...........................................................................................................................................................................
Phenampromide ......................................................................................................................................................................
Phenoperidine ..........................................................................................................................................................................
Piritramide ................................................................................................................................................................................
Proheptazine ............................................................................................................................................................................
Properidine ..............................................................................................................................................................................
Racemoramide ........................................................................................................................................................................
Trimeperidine ...........................................................................................................................................................................
Phenomorphan ........................................................................................................................................................................
Propiram ..................................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..............................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ......................................................................................................................
Tilidine .....................................................................................................................................................................................
Para-Fluorofentanyl .................................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................................
Butyryl Fentanyl .......................................................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................................
Thiofentanyl .............................................................................................................................................................................
Amphetamine ...........................................................................................................................................................................
Methamphetamine ...................................................................................................................................................................
Lisdexamfetamine ....................................................................................................................................................................
Phenmetrazine .........................................................................................................................................................................
Methylphenidate ......................................................................................................................................................................
Amobarbital ..............................................................................................................................................................................
Pentobarbital ............................................................................................................................................................................
Secobarbital .............................................................................................................................................................................
Glutethimide .............................................................................................................................................................................
Nabilone ...................................................................................................................................................................................
1-Phenylcyclohexylamine ........................................................................................................................................................
Phencyclidine ...........................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................................
Phenylacetone .........................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................................
Alphaprodine ............................................................................................................................................................................
Anileridine ................................................................................................................................................................................
Coca Leaves ............................................................................................................................................................................
Cocaine ....................................................................................................................................................................................
Codeine ...................................................................................................................................................................................
Etorphine HCl ..........................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................................
Oxycodone ...............................................................................................................................................................................
Hydromorphone .......................................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................................
Ecgonine ..................................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................................
Levomethorphan ......................................................................................................................................................................
Levorphanol .............................................................................................................................................................................
Isomethadone ..........................................................................................................................................................................
Meperidine ...............................................................................................................................................................................
Meperidine intermediate-A ......................................................................................................................................................
VerDate Sep<11>2014
18:55 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
E:\FR\FM\07FEN1.SGM
07FEN1
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9812
9813
9814
9815
9821
9822
9830
9831
9832
9833
9835
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8501
8603
9010
9020
9040
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
2575
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Drug
code
Controlled substance
Meperidine intermediate-B ......................................................................................................................................................
Meperidine intermediate-C ......................................................................................................................................................
Metazocine ..............................................................................................................................................................................
Methadone ...............................................................................................................................................................................
Methadone intermediate ..........................................................................................................................................................
Metopon ...................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................................
Morphine ..................................................................................................................................................................................
Oripavine .................................................................................................................................................................................
Thebaine ..................................................................................................................................................................................
Dihydroetorphine .....................................................................................................................................................................
Opium, raw ..............................................................................................................................................................................
Opium extracts ........................................................................................................................................................................
Opium fluid extract ..................................................................................................................................................................
Opium tincture .........................................................................................................................................................................
Opium, powdered ....................................................................................................................................................................
Opium, granulated ...................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................................
Opium poppy ...........................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................................
Noroxymorphone .....................................................................................................................................................................
Poppy Straw Concentrate .......................................................................................................................................................
Phenazocine ............................................................................................................................................................................
Piminodine ...............................................................................................................................................................................
Racemethorphan .....................................................................................................................................................................
Racemorphan ..........................................................................................................................................................................
Alfentanil ..................................................................................................................................................................................
Remifentanil .............................................................................................................................................................................
Sufentanil .................................................................................................................................................................................
Carfentanil ...............................................................................................................................................................................
Tapentadol ...............................................................................................................................................................................
Bezitramide ..............................................................................................................................................................................
Fentanyl ...................................................................................................................................................................................
Moramide-intermediate ............................................................................................................................................................
The company plans to import small
quantities of the listed controlled
substances for the National Institute on
Drug Abuse (NIDA) for research
activities. The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes.
Dated: January 2, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01523 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Microgenics Corporation
Thermo Fisher Scientific
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 11, 2019. Such persons
may also file a written request for a
hearing on the application on or before
March 11, 2019.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated his
SUPPLEMENTARY INFORMATION:
Drug
code
Cathinone ................................................................................................................................................................................
18:55 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
23, 2018, Microgenics Corporation/
Thermo Fisher Scientific located at
46500 Kato Rd., Fremont, California
94538, applied to be registered as an
importer of the below listed basic
classes of controlled substance listed in
schedules I and II.
Controlled substance
VerDate Sep<11>2014
9233
9234
9240
9250
9254
9260
9273
9300
9330
9333
9334
9600
9610
9620
9630
9639
9640
9648
9650
9652
9668
9670
9715
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
E:\FR\FM\07FEN1.SGM
07FEN1
1235
Schedule
I
Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2571-2575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01523]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Research Triangle
Institute
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before March 11, 2019. Such
persons may also file a written request for a hearing on the
application on or before March 11, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to
[[Page 2572]]
exercise all necessary functions with respect to the promulgation and
implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on May 2,
2016, Research Triangle Institute, 3040 East Cornwallis Road, Hermann
Bldg., Room 106, Research Triangle Park, North Carolina 27709 has
applied to be registered as an importer of the following basic classes
of controlled substances.
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).......... 1233 I
Cathinone................................... 1235 I
Methcathinone............................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC).......... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone)..... 1248 I
4-Methyl-N-ethylcathinone (4-MEC)........... 1249 I
Naphyrone................................... 1258 I
N-Ethylamphetamine.......................... 1475 I
N,N-Dimethylamphetamine..................... 1480 I
Fenethylline................................ 1503 I
Aminorex.................................... 1585 I
4-Methylaminorex (cis isomer)............... 1590 I
Gamma Hydroxybutyric Acid................... 2010 I
Methaqualone................................ 2565 I
Mecloqualone................................ 2572 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 6250 I
indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-methoxyphenylacetyl)
indole).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- 7012 I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)..... 7019 I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone.
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- 7031 I
2-yl)-1-(cyclohexylmethyl)1H-indazole-3-
carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- 7048 I
1H-indazole-3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 7081 I
indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I
naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 7122 I
indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)..... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) 7203 I
indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- 7225 I
1H-indole-3-carboxylate).
Alpha-ethyltryptamine....................... 7249 I
Ibogaine.................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)- 7297 I
3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.................. 7315 I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine 7348 I
(2C-T-7).
Marihuana................................... 7360 I
Tetrahydrocannabinols....................... 7370 I
Parahexyl................................... 7374 I
Mescaline................................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine................. 7390 I
4-Bromo-2,5-dimethoxyamphetamine............ 7391 I
4-Bromo-2,5-dimethoxyphenethylamine......... 7392 I
4-Methyl-2,5-dimethoxyamphetamine........... 7395 I
2,5-Dimethoxyamphetamine.................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 7398 I
indole).
2,5-Dimethoxy-4-ethylamphetamine............ 7399 I
3,4-Methylenedioxyamphetamine............... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine..... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine..... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine....... 7404 I
3,4-Methylenedioxymethamphetamine........... 7405 I
4-Methoxyamphetamine........................ 7411 I
Peyote...................................... 7415 I
5-Methoxy-N-N-dimethyltryptamine............ 7431 I
[[Page 2573]]
Alpha-methyltryptamine...................... 7432 I
Bufotenine.................................. 7433 I
Diethyltryptamine........................... 7434 I
Dimethyltryptamine.......................... 7435 I
Psilocybin.................................. 7437 I
Psilocyn.................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine......... 7439 I
N-Ethyl-1-phenylcyclohexylamine............. 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine........... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine....... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine...... 7473 I
N-Ethyl-3-piperidyl benzilate............... 7482 I
N-Methyl-3-piperidyl benzilate.............. 7484 I
N-Benzylpiperazine.......................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone (4- 7498 I
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine 7508 I
(2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine 7509 I
(2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)... 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine 7518 I
(2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine 7519 I
(2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine 7521 I
(2C-N).
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I
ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone)....... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone.................................... 7541 I
Pentylone................................... 7542 I
alpha-pyrrolidinopentiophenone ([alpha]-PVP) 7545 I
alpha-pyrrolidinobutiophenone ([alpha]-PBP). 7546 I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) 7694 I
indole).
Acetyldihydrocodeine........................ 9051 I
Benzylmorphine.............................. 9052 I
Codeine-N-oxide............................. 9053 I
Cyprenorphine............................... 9054 I
Desomorphine................................ 9055 I
Etorphine (except HCl)...................... 9056 I
Codeine methylbromide....................... 9070 I
Dihydromorphine............................. 9145 I
Difenoxin................................... 9168 I
Heroin...................................... 9200 I
Hydromorphinol.............................. 9301 I
Methyldesorphine............................ 9302 I
Methyldihydromorphine....................... 9304 I
Morphine methylbromide...................... 9305 I
Morphine methylsulfonate.................... 9306 I
Morphine-N-oxide............................ 9307 I
Myrophine................................... 9308 I
Nicocodeine................................. 9309 I
Nicomorphine................................ 9312 I
Normorphine................................. 9313 I
Pholcodine.................................. 9314 I
Thebacon.................................... 9315 I
Acetorphine................................. 9319 I
Drotebanol.................................. 9335 I
Acetylmethadol.............................. 9601 I
Allylprodine................................ 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine.............................. 9604 I
Alphamethadol............................... 9605 I
Benzethidine................................ 9606 I
Betacetylmethadol........................... 9607 I
Betameprodine............................... 9608 I
Betamethadol................................ 9609 I
Betaprodine................................. 9611 I
Clonitazene................................. 9612 I
Dextromoramide.............................. 9613 I
Diampromide................................. 9615 I
Diethylthiambutene.......................... 9616 I
Dimenoxadol................................. 9617 I
Dimepheptanol............................... 9618 I
[[Page 2574]]
Dimethylthiambutene......................... 9619 I
Dioxaphetyl butyrate........................ 9621 I
Dipipanone.................................. 9622 I
Ethylmethylthiambutene...................... 9623 I
Etonitazene................................. 9624 I
Etoxeridine................................. 9625 I
Furethidine................................. 9626 I
Hydroxypethidine............................ 9627 I
Ketobemidone................................ 9628 I
Levomoramide................................ 9629 I
Levophenacylmorphan......................... 9631 I
Morpheridine................................ 9632 I
Noracymethadol.............................. 9633 I
Norlevorphanol.............................. 9634 I
Normethadone................................ 9635 I
Norpipanone................................. 9636 I
Phenadoxone................................. 9637 I
Phenampromide............................... 9638 I
Phenoperidine............................... 9641 I
Piritramide................................. 9642 I
Proheptazine................................ 9643 I
Properidine................................. 9644 I
Racemoramide................................ 9645 I
Trimeperidine............................... 9646 I
Phenomorphan................................ 9647 I
Propiram.................................... 9649 I
1-Methyl-4-phenyl-4-propionoxypiperidine.... 9661 I
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine.................................... 9750 I
Para-Fluorofentanyl......................... 9812 I
3-Methylfentanyl............................ 9813 I
Alpha-methylfentanyl........................ 9814 I
Acetyl-alpha-methylfentanyl................. 9815 I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Butyryl Fentanyl............................ 9822 I
Beta-hydroxyfentanyl........................ 9830 I
Beta-hydroxy-3-methylfentanyl............... 9831 I
Alpha-methylthiofentanyl.................... 9832 I
3-Methylthiofentanyl........................ 9833 I
Thiofentanyl................................ 9835 I
Amphetamine................................. 1100 II
Methamphetamine............................. 1105 II
Lisdexamfetamine............................ 1205 II
Phenmetrazine............................... 1631 II
Methylphenidate............................. 1724 II
Amobarbital................................. 2125 II
Pentobarbital............................... 2270 II
Secobarbital................................ 2315 II
Glutethimide................................ 2550 II
Nabilone.................................... 7379 II
1-Phenylcyclohexylamine..................... 7460 II
Phencyclidine............................... 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP)... 8333 II
Phenylacetone............................... 8501 II
1-Piperidinocyclohexanecarbonitrile......... 8603 II
Alphaprodine................................ 9010 II
Anileridine................................. 9020 II
Coca Leaves................................. 9040 II
Cocaine..................................... 9041 II
Codeine..................................... 9050 II
Etorphine HCl............................... 9059 II
Dihydrocodeine.............................. 9120 II
Oxycodone................................... 9143 II
Hydromorphone............................... 9150 II
Diphenoxylate............................... 9170 II
Ecgonine.................................... 9180 II
Ethylmorphine............................... 9190 II
Hydrocodone................................. 9193 II
Levomethorphan.............................. 9210 II
Levorphanol................................. 9220 II
Isomethadone................................ 9226 II
Meperidine.................................. 9230 II
Meperidine intermediate-A................... 9232 II
[[Page 2575]]
Meperidine intermediate-B................... 9233 II
Meperidine intermediate-C................... 9234 II
Metazocine.................................. 9240 II
Methadone................................... 9250 II
Methadone intermediate...................... 9254 II
Metopon..................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms). 9273 II
Morphine.................................... 9300 II
Oripavine................................... 9330 II
Thebaine.................................... 9333 II
Dihydroetorphine............................ 9334 II
Opium, raw.................................. 9600 II
Opium extracts.............................. 9610 II
Opium fluid extract......................... 9620 II
Opium tincture.............................. 9630 II
Opium, powdered............................. 9639 II
Opium, granulated........................... 9640 II
Levo-alphacetylmethadol..................... 9648 II
Opium poppy................................. 9650 II
Oxymorphone................................. 9652 II
Noroxymorphone.............................. 9668 II
Poppy Straw Concentrate..................... 9670 II
Phenazocine................................. 9715 II
Piminodine.................................. 9730 II
Racemethorphan.............................. 9732 II
Racemorphan................................. 9733 II
Alfentanil.................................. 9737 II
Remifentanil................................ 9739 II
Sufentanil.................................. 9740 II
Carfentanil................................. 9743 II
Tapentadol.................................. 9780 II
Bezitramide................................. 9800 II
Fentanyl.................................... 9801 II
Moramide-intermediate....................... 9802 II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the National Institute on Drug Abuse (NIDA)
for research activities. The company plans to import analytical
reference standards for distribution to its customers for research and
analytical purposes.
Dated: January 2, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01523 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P